PotentiaMetrics Announces the Fifth and Sixth Members of its MyCancerJourney Clinical Advisory Board; Jonathan Heinlen, M.D. and Tara Kaufmann, M.D.

April 8, 2019

Austin, Texas / PRWEB/ April 8, 2019 –POTENTIAMETRICS, an Austin, TX based healthcare data and artificial intelligence company, announced the addition of Jonathan Heinlen, M.D. and Tara Kaufmann, M.D. to the ranks of its stellar advisory board of specialists, MDs and medical researchers.

PotentiaMetrics Announces Additions to its Clinical Advisory Board with Doctors Carolyn Presley and Michael Papagikos

April 1, 2019

Austin, Texas / PRWEB/ April 1, 2019 –POTENTIAMETRICS, an Austin, TX based healthcare data and artificial intelligence company, announced the addition of Carolyn Presley, M.D. MHS and Michael Papagikos, M.D to the ranks of its stellar group of specialists, MDs and medical researchers committed to empowering patients with the strongest data in cancer.

Potentiametrics Announces the Addition of George Lundberg, M.D. to MyCancerJourney Clinical Advisory Board

March 25, 2019

Austin, Texas / PRWEB/ March 25, 2019 –POTENTIAMETRICS, an Austin, TX based healthcare data and artificial intelligence company, announced the formation of The MyCancerJourney Clinical Advisory Board, a stellar group of specialists, MDs, and medical researchers committed to empowering patients with the strongest data in cancer.

PotentiaMetrics Announces the Formation of Clinical Advisory Board Committed to Empowering Patients with Cancer using AI Platform — MyCancerJourney

March 18, 2019

Austin, Texas / PRWEB/ March 18, 2019 — POTENTIAMETRICS, an Austin, TX based healthcare data and analytics company, announced the formation of The MyCancerJourney Clinical Advisory Board (CAB).

PotentiaMetrics and Ascend Collaborate to Launch Disruptive Cancer Outcomes Platform

September 27, 2018

Austin, Texas / PRWEB/ September 27, 2018 — MyCancerJourney empowers patients with actionable information to improve the patient experience, improve outcomes while saving millions of dollars for patients and self-insured employers.

PotentiaMetrics selected as Top 10 Innovators in Cancer at MedCity’s CONVERGE Conference in Philadelphia

July 12, 2018

Study: Cerebral oximetry monitoring linked to fewer complications after cardiac surgery

Written by Jessica Kim Cohen | Becker’s Hospital Review | January 8, 2018

Monitoring cardiac surgery patients’ cerebral oximetry levels may lead to reduced surgical complications and 30-day readmissions, according to a study published in the Harvard Health Policy Review Jan. 7.

4 questions with PotentiaMetrics CEO Robert Palmer on personalized healthcare

Written by Jessica Kim Cohen | Becker’s IT & CIO Review | Jan 3, 2018

Robert Palmer boasts 20-plus years of experience in data analytics — but he chose to focus his career on healthcare after his father was diagnosed with metastatic cancer.

PotentiaMetrics recognized by GuideWell for innovative and disruptive Analytics and AI platform for cancer patients

Winner of the People’s Choice Award | April 27, 2017

PotentiaMetrics recognized by Joe Biden (Biden Foundation) at SXSW for innovation in cancer outcomes Analytics and AI

March 12, 2017

PotentiaMetrics Selected for GuideWell Innovation and Healthbox Program

May 31, 2016

AUSTIN, Texas, May 31, 2016 /PRNewswire/ — PotentiaMetrics announces selection to participate in The Healthbox Florida Studio in Partnership with GuideWell Innovation, an eight-week studio at the new GuideWell Innovation CoRE™ (Collaborative Resource Ecosystem) space in Lake Nona Medical City, Orlando, Florida.